Inaktiver Wert

Andere Sprachen Neurokine Pharmaceuticals Inc Other OTC

Aktien

CAC611561100

Schlusskurs Other OTC Andere Börsenplätze
- ^USD	-

01.05.	BetterLife Pharma treibt die IND-zulassenden Studien für BETR-001 voran	MT
01.05.	BetterLife Pharma Inc. macht Fortschritte bei den IND-Zulassungsstudien für BETR-001	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

BetterLife Announces Intent to Complete Private Placement of Units	04.05.
BetterLife Announces Intent to Complete Private Placement of Units	04.05.
BetterLife Pharma Inc. announced that it expects to receive CAD 0.5 million in funding	03.05.
BetterLife Pharma Advances IND-enabling Studies For BETR-001	01.05.
BetterLife Advances BETR-001 IND-enabling Studies	01.05.
BetterLife Advances BETR-001 IND-enabling Studies	01.05.
BetterLife Pharma Inc. Advances BETR-001 IND-Enabling Studies	01.05.
BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	15.04.
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	11.04.
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	11.04.
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001	03.04.
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001	03.04.
BetterLife Pharma Inc. announced that it has received CAD 1.168 million in funding	03.04.
BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University	04.03.
BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University	04.03.
BetterLife Pharma Inc. announced that it expects to receive CAD 0.1 million in funding	04.03.
BetterLife Pharma Inc. announced that it has received CAD 0.065 million in funding	04.03.
BetterLife Closes Convertible Debentures For Further Development of BETR-001	02.01.
BetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001	02.01.
BetterLife Pharma Inc. announced that it has received CAD 0.3 million in funding	02.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Neurokine Pharmaceuticals Inc Other OTC

Aktien

CAC611561100

Andere Sprachen

Filter